Table 1.
Clinicopathological indicators of individuals in the TCGA-STAD cohort
| Clinicopathological indicators | Type | TCGA-STAD cohort (n = 371) |
|---|---|---|
| Age | <=65 | 163 (43.94%) |
| >65 | 205 (55.26%) | |
| Not available | 3(0.80%) | |
| Gender | Female | 133 (35.85%) |
| Male | 238(64.15%) | |
| Grade | G1 | 10 (2.70%) |
| G2 | 134 (36.12%) | |
| G3 | 218 (58.76%) | |
| Not available | 9 (2.42%) | |
| TNM-Stage | Stage I | 50 (13.48%) |
| Stage II | 111 (29.92%) | |
| Stage III | 149 (40.16%) | |
| Stage IV | 38 (10.24%) | |
| Not available | 23 (6.20%) | |
| T-Stage | T1 | 18 (4.85%) |
| T2 | 78 (21.02%) | |
| T3 | 167 (45.01%) | |
| T4 | 100 (26.95%) | |
| Not available | 8 (2.16%) | |
| N-Stage | N0 | 108 (29.11%) |
| N1 | 97 (26.15%) | |
| N2 | 74 (19.95%) | |
| N3 | 74 (19.95%) | |
| Not available | 18 (4.85%) | |
| M-Stage | M0 | 328 (88.41%) |
| M1 | 25 (6.74%) | |
| Not available | 18 (4.85%) |